<p><strong>Bio-Techne 批准了与拟议合并相关的高管现金保留奖金。</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>个人</strong></td>
<td>Kim Kelderman</td>
<td>Jim Hippel</td>
<td>William Geist</td>
<td>Shane Bohnen</td>
<td>Steve Crouse</td>
</tr>
<tr>
<td><strong>角色</strong></td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
</tr>
<tr>
<td><strong>变更类型</strong></td>
<td>批准保留奖金</td>
<td>批准保留奖金</td>
<td>批准保留奖金</td>
<td>批准保留奖金</td>
<td>批准保留奖金</td>
</tr>
<tr>
<td><strong>生效日期</strong></td>
<td>2026 年 6 月 23 日（在合并协议签署后生效）</td>
<td>2026 年 6 月 23 日（在合并协议签署后生效）</td>
<td>2026 年 6 月 23 日（在合并协议签署后生效）</td>
<td>2026 年 6 月 23 日（在合并协议签署后生效）</td>
<td>2026 年 6 月 23 日（在合并协议签署后生效）</td>
</tr>
<tr>
<td><strong>原因</strong></td>
<td>鼓励保留并持续表现直到生效时间</td>
<td>鼓励保留并持续表现直到生效时间</td>
<td>鼓励保留并持续表现直到生效时间</td>
<td>鼓励保留并持续表现直到生效时间</td>
<td>鼓励保留并持续表现直到生效时间</td>
</tr>
<tr>
<td><strong>替代信息</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
<tr>
<td><strong>背景详情</strong></td>
<td>保留协议提供$2,120,976 一次性付款；在归属日期支付，需满足雇佣或符合条件的终止及释放执行</td>
<td>保留协议提供$1,541,510 一次性付款；在归属日期支付，需满足雇佣或符合条件的终止及释放执行</td>
<td>保留协议提供$1,161,014 一次性付款；在归属日期支付，需满足雇佣或符合条件的终止及释放执行</td>
<td>保留协议提供$971,097 一次性付款；在归属日期支付，需满足雇佣或符合条件的终止及释放执行</td>
<td>保留协议提供$910,263 一次性付款；在归属日期支付，需满足雇佣或符合条件的终止及释放执行</td>
</tr>
<tr>
<td><strong>董事会/委员会角色变更</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
</tbody>
</table>
<p>原始 SEC 文件：BIO-TECHNE Corp [ TECH ] - 8-K -2026 年 6 月 25 日
<strong>免责声明</strong></p>
<p>这是一个由人工智能生成的摘要。可能包含不准确的信息。请考虑与来源核实重要信息。请注意，此摘要仅基于提交给 SEC 的文件。</p>

TECH

<p>Bio-Techne 为五位指定高管，包括 Kim Kelderman 和 Jim Hippel，批准了现金保留奖金，以配合一项拟议中的合并。这些奖金的金额从约 91 万美元到 210 万美元不等，旨在鼓励高管们在合并生效日期 2026 年 6 月 23 日之前继续留任。奖金的支付取决于持续的雇佣关系或符合条件的终止，以及签署解除协议</p>

<p><strong>Bio-Techne approved cash retention bonuses for named executive officers in connection with the contemplated merger.</strong></p>
<div class="lb-trans"><p><strong>Bio-Techne 批准了与拟议合并相关的高管现金保留奖金。</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Individual</strong></td>
<td>Kim Kelderman</td>
<td>Jim Hippel</td>
<td>William Geist</td>
<td>Shane Bohnen</td>
<td>Steve Crouse</td>
</tr>
<tr>
<td><strong>Role</strong></td>
<td>Named executive officer</td>
<td>Named executive officer</td>
<td>Named executive officer</td>
<td>Named executive officer</td>
<td>Named executive officer</td>
</tr>
<tr>
<td><strong>Type of Change</strong></td>
<td>Retention bonus approved</td>
<td>Retention bonus approved</td>
<td>Retention bonus approved</td>
<td>Retention bonus approved</td>
<td>Retention bonus approved</td>
</tr>
<tr>
<td><strong>Effective Date</strong></td>
<td>June 23, 2026 (effective upon execution of Merger Agreement)</td>
<td>June 23, 2026 (effective upon execution of Merger Agreement)</td>
<td>June 23, 2026 (effective upon execution of Merger Agreement)</td>
<td>June 23, 2026 (effective upon execution of Merger Agreement)</td>
<td>June 23, 2026 (effective upon execution of Merger Agreement)</td>
</tr>
<tr>
<td><strong>Reason</strong></td>
<td>To encourage retention and continued performance until the Effective Time</td>
<td>To encourage retention and continued performance until the Effective Time</td>
<td>To encourage retention and continued performance until the Effective Time</td>
<td>To encourage retention and continued performance until the Effective Time</td>
<td>To encourage retention and continued performance until the Effective Time</td>
</tr>
<tr>
<td><strong>Replacement Info</strong></td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
</tr>
<tr>
<td><strong>Background Details</strong></td>
<td>Retention agreement provides $2,120,976 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td>
<td>Retention agreement provides $1,541,510 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td>
<td>Retention agreement provides $1,161,014 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td>
<td>Retention agreement provides $971,097 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td>
<td>Retention agreement provides $910,263 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td>
</tr>
<tr>
<td><strong>Board/Committee Role Changes</strong></td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>个人</strong></td>
<td>Kim Kelderman</td>
<td>Jim Hippel</td>
<td>William Geist</td>
<td>Shane Bohnen</td>
<td>Steve Crouse</td>
</tr>
<tr>
<td><strong>角色</strong></td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
</tr>
<tr>
<td><strong>变更类型</strong></td>
<td>批准保留奖金</td>
<td>批准保留奖金</td>
<td>批准保留奖金</td>
<td>批准保留奖金</td>
<td>批准保留奖金</td>
</tr>
<tr>
<td><strong>生效日期</strong></td>
<td>2026 年 6 月 23 日（在合并协议签署后生效）</td>
<td>2026 年 6 月 23 日（在合并协议签署后生效）</td>
<td>2026 年 6 月 23 日（在合并协议签署后生效）</td>
<td>2026 年 6 月 23 日（在合并协议签署后生效）</td>
<td>2026 年 6 月 23 日（在合并协议签署后生效）</td>
</tr>
<tr>
<td><strong>原因</strong></td>
<td>鼓励保留并持续表现直到生效时间</td>
<td>鼓励保留并持续表现直到生效时间</td>
<td>鼓励保留并持续表现直到生效时间</td>
<td>鼓励保留并持续表现直到生效时间</td>
<td>鼓励保留并持续表现直到生效时间</td>
</tr>
<tr>
<td><strong>替代信息</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
<tr>
<td><strong>背景详情</strong></td>
<td>保留协议提供$2,120,976 一次性付款；在归属日期支付，需满足雇佣或符合条件的终止及释放执行</td>
<td>保留协议提供$1,541,510 一次性付款；在归属日期支付，需满足雇佣或符合条件的终止及释放执行</td>
<td>保留协议提供$1,161,014 一次性付款；在归属日期支付，需满足雇佣或符合条件的终止及释放执行</td>
<td>保留协议提供$971,097 一次性付款；在归属日期支付，需满足雇佣或符合条件的终止及释放执行</td>
<td>保留协议提供$910,263 一次性付款；在归属日期支付，需满足雇佣或符合条件的终止及释放执行</td>
</tr>
<tr>
<td><strong>董事会/委员会角色变更</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
</tbody>
</table>
</div><p>Original SEC Filing: BIO-TECHNE Corp [ TECH ] - 8-K - Jun. 25, 2026
<strong>Disclaimer</strong></p>
<div class="lb-trans"><p>原始 SEC 文件：BIO-TECHNE Corp [ TECH ] - 8-K -2026 年 6 月 25 日
<strong>免责声明</strong></p>
</div><p>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</p>
<div class="lb-trans"><p>这是一个由人工智能生成的摘要。可能包含不准确的信息。请考虑与来源核实重要信息。请注意，此摘要仅基于提交给 SEC 的文件。</p>
</div>

Bio-Techne 公司批准了 Kim Kelderman 和 Jim Hippel 的留任奖金